Literature DB >> 32385933

An overview of treatment options for mild-to-moderate acne based on American Academy of Dermatology, European Academy of Dermatology and Venereology, and Italian Society of Dermatology and Venereology guidelines.

Claudio Conforti1, Camilla Chello2, Roberta Giuffrida3, Nicola di Meo1, Iris Zalaudek1, Caterina Dianzani2.   

Abstract

Acne is a common inflammatory skin disorder affecting the pilosebaceous unit. Patients with mild-to-moderate acne can be treated with a combination of topical, systemic, and physical therapeutic approaches, with different results depending on patient, disease, and treatment characteristics. Herein we describe and discuss the common and alternative treatment options used for mild-to-moderate acne, by comparing three widely distributed guidelines (American Academy of Dermatology, European Academy of Dermatology and Venereology, and Italian Society of Dermatology and Venereology.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  acne; acne mild-to-moderate; acne vulgaris; antibiotics; guidelines; retinoids; therapy

Mesh:

Year:  2020        PMID: 32385933     DOI: 10.1111/dth.13548

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

Review 1.  Personal protective equipment-related occupational dermatoses during COVID-19 among health care workers: A worldwide systematic review.

Authors:  Bryan M H Keng; Wee Hoe Gan; Yew Chong Tam; Choon Chiat Oh
Journal:  JAAD Int       Date:  2021-09-01

Review 2.  Truncal Acne: An Overview.

Authors:  Yu Ri Woo; Hei Sung Kim
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

3.  Effective Intense Pulsed Light Protocol in the Treatment of Moderate to Severe Acne Vulgaris.

Authors:  Piccolo Domenico; Kostaki Dimitra; Crisman Giuliana; Dianzani Caterina; Avallone Gianluca; Giuffrida Roberta; Guarneri Fabrizio; Guida Stefania; Zalaudek Iris; Fusco Irene; Conforti Claudio
Journal:  Front Med (Lausanne)       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.